Scientists at the Albert Einstein College of Medicine of Yeshiva University recently discovered vitamin C kills drug resistant tuberculosis in laboratory cultures, which opens a new door for immunization development against TB. The study, led by William Jacobs, Jr., professor … Read More »
The World Health Organization reported on Wednesday that there has been an outbreak of a wild poliovirus type 1 in the Horn of Africa. Polio, also known as poliomyelitis, is an acute viral infectious disease that comes in a variety … Read More »
The European Center for Disease Prevention and Control is preparing to make changes in the monitoring of rubella throughout Europe to help align the data, according to a recent report by the agency. While most European Union and European Economic … Read More »
iBio, Inc., a Newark, Delaware-based biotechnology company, announced on Wednesday the production of a vaccine candidate for the newly emerged H7N9 influenza virus by an independent third-party laboratory using iBio’s iBioLaunch platform. The laboratory achieved the validation milestone for the … Read More »
The United Nations Children’s Fund and its partners announced on Tuesday the launch of an emergency immunization program against measles in the Central African Republic, estimated to reach some 125,000 children. The campaign began on Wednesday and will last for … Read More »
The Joint U.N. Programme on HIV/AIDS announced on Tuesday that the number of people in Africa receiving antiretroviral treatment for HIV has increased from less than 1 million in 2005 to more than 7 million in 2012. The UNAIDS report showed … Read More »
Agenus, a Lexington, Massachusetts-based biotechnology company, announced the start of enrollment on Wednesday for a Phase II study of a Prophage G-200 vaccine in combination with bevacizumab for one type of brain tumor. The large, randomized trial to test Heat … Read More »
Soligenix, a Princeton, New Jersey-based clinical stage biopharmaceutical company, announced on Wednesday that the U.S. Patent and Trademark Office granted a patent for the company’s ThermoVax vaccine thermostabilization technology. ThermoVax is a novel method to stabilize vaccines adjuvanted with aluminum … Read More »